AP-401

About Advance Pharmaceutical

Advance Pharmaceutical is dedicated to translating scientific discoveries into transformative medicines for patients with high unmet medical needs. The company's core technology enables the precise targeting of disease pathways, particularly in oncology and genetic disorders. With a robust pipeline of candidates in various stages of development and a strong leadership team, the company is strategically positioned for growth. Its focus on both internal development and strategic partnerships aims to accelerate the delivery of new therapies to market.

About Alphageneron Pharmaceuticals

Alphageneron Pharmaceuticals is a clinical-stage biotech pioneering a targeted NK cell therapy platform centered on the cancer-specific biomarker mHsp70. Its pipeline includes both autologous and allogeneic NK cell therapies, as well as a CAR-NK candidate derived from induced pluripotent stem cells (iPSCs). Led by a founder with a history of biotech ventures and a board featuring seasoned industry and academic experts, the company is positioned in the competitive but high-potential cell therapy space for solid tumors.

Therapeutic Areas